Sofinnova Investments, Inc. Astrazeneca PLC Transaction History
Sofinnova Investments, Inc.
- $1.63 Billion
- Q3 2025
A detailed history of Sofinnova Investments, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 823,933 shares of AZN stock, worth $73.7 Million. This represents 3.87% of its overall portfolio holdings.
Number of Shares
823,933
Previous 293,661
180.57%
Holding current value
$73.7 Million
Previous $20.5 Million
208.04%
% of portfolio
3.87%
Previous 1.39%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...